3/14/2013

The FDA proposed approving Alzheimer's disease drugs that subtly improve memory or reasoning in clinical trial participants with mild or no symptoms. Researchers praised the proposal. The proposal was published online in the New England Journal of Medicine and is open for comments.

Related Summaries